Report to the President on Reengineering the Influenza Vaccine Production Enterprise to Meet the Challenges of Pandemic Influenza [open pdf - 3MB]
This report "examines how the Nation can more rapidly and reliably produce effective vaccines, at a sufficient scale to protect all of the Nation's residents, in response to the emergence of pandemic influenza. [...]. The report recommends a number of steps that can be taken over the next one to two years to cut several weeks from the time currently needed to produce the first doses of a new vaccine. In addition, PCAST [President's Council of Advisors on Science and Technology] identified actions that could greatly improve the reliability of the vaccine manufacturing enterprise over a two to ten year timeframe, further shortening the time required to provide vaccine to the entire U.S. population. Several of the recommendations can also improve the Nation's ability to mount medical counter-measures against a variety of infectious agents. Finally, the successful production of an effective pandemic influenza vaccine requires coordinated actions on the part of government and the private sector; as part of its review, PCAST identified ways to better utilize public-private partnerships to optimize the Nation's vaccine production enterprise."
White House: http://www.whitehouse.gov/